
Icosagen is an Estonian biotechnology companies providing custom research programs and services to the Biopharmaceutical industry, including antibody discovery, protein production, and GMP manufacturing. Formed in 1999 as Quattromed AS, it was renamed Icosagen in 2009. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Icosagen (Estonia), Estonia, covering academic research published from 2004 to 2024. Read More.
Open Access Percentage
75%
Total 
 Publications
75
Total Open 
 Publications
56
Total 
 Citations
1.4K
Open Access 
 Percentage
75%
Total 
 Publications
75
Total Open 
 Publications
56
Total 
 Citations
1.4K
Breakdown
Publisher Open
20%
Both
50%
Other Platform Open
3%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 72%
35
Hybrid 18%
9
No Guarantees 10%
5
Other Platform Open
Domain 76%
28
Institution 43%
16
Other Internet 27%
10
Public 8%
3
Preprint 0%
0
Other Platform Locations
Name  | Platform Type  | Publications  | 
|---|---|---|
PubMed Central  | Domain  | 28 | 
DOI  | Other Internet  | 10 | 
DANS - Data Archiving and Networked Services  | Institution  | 7 | 
Le Centre pour la Communication Scientifique Directe - HAL - Diderot  | Institution  | 3 | 
Figshare  | Public  | 3 | 
University of Tartu - DSpace repository  | Institution  | 2 | 
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI  | Institution  | 2 | 
Europe PMC  | Domain  | 2 | 
University of Oslo - Duo Research Archive  | Institution  | 1 | 
University of Helsinki - Helda  | Institution  | 1 |